Related Experiment Video
Updated: Dec 8, 2025

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Protein Glycosylation: "New-yet-Old" Target for Immunotherapy
Jaydeep Bhat1, Dieter Kabelitz2
1Metabolic Programming, TUM School of Life Sciences Weihenstephan; ZIEL-Institute for Food and Health, Technical University of Munich (TUM), Freising, Germany. bhatvjay24@gmail.com dietrich.kabelitz@uksh.de.
Abstract:
The use of checkpoint monotherapy in treating cancer has limited success. Post-translational modifications (PTM) of proteins such as glycosylation might have clinical implications due to distinct modifications found in diseases and its regulatory role in the immunometabolic gene expression. Such novel mechanistic targets hold great promise for combined immunotherapy.See related article by Shi et al., p. 5990.
More Related Videos
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Proteoglycans
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Matrix Proteoglycans and Glycoproteins

